GLP-1 drug shows little benefit for people with Parkinson's disease, trial finds
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.
Statins only add 3 DAYS to your life?!?
- Prioritize Your Health and Safety: Best Practices for Medical Couriers 🛡️ - Zoul
- Computational tool extracting disease-specific drug response signatures could improve cancer treatment discoveries
- Wacky Marxist Colombian President Gustavo Petro Issues an Incredibly Bizarre Response to President Trump While Threatening Retaliation - MeighTimbol
- Found Footage Horror On Tubi With Unlikely Director Tries To Capture Bigfoot - Robert Scucci
- Top Strategies for Paying Off Debt Fast - Zoul
- Preeclampsia Risk Similar With 81 mg and 162 mg Aspirin
Chicago Mayor Protects Migrant Criminals
- Marvel Television’s Daredevil: Born Again | Official Trailer | Disney + - Staff
- Who Cares for the Caregivers? The Push for Laws to Protect Nurses’ Mental Health
- Remote Data Entry: $16.50-$20/Hr., College Not Required - ratrace
- New Research Shows How Juice Cleanses Could Actually Affect Your Gut and Mouth—And the News Isn't Great - Sarah Garone
- Trump issues executive order to ban gender-affirming care for minors - MeighTimbol
- How to use your Google TV or Chromecast to stream via a VPN - Aaron Kim